Streptococcus pneumoniae is a major cause of morbidity and mortality globally causing more deaths than any other infectious disease. At highest risk are the smallest children and the elderly with ∼1 million children below 5 years of age dying yearly (Centers for Disease Control 2008 ). Pneumococcal diseases range from mild respiratory tract mucosal infections such as sinusitis to more severe diseases such as pneumonia, septicemia, and meningitis.
We are pleased to support research into Streptococcus with highly specific monoclonal antibodies to the bacterium.
Streptococcus pneumoniae is a lancet-shaped, gram-positive, facultative anaerobic bacterium.
In humans, S. pneumoniae primarily colonizes the nasopharynx and transmission occurs from person-to-person via respiratory secretions from patients infected with S. pneumoniae, and from healthy carriers. In susceptible individuals, the bacteria can spread to the lower respiratory tract, the inner ear or sinuses causing different types of illness referred to as pneumococcal disease.
Worldwide, S. pneumoniae is the major cause of pneumonia, sepsis, and meningitis and is the leading cause of community acquired pneumonia in young children and the elderly.
Streptococcus pneumoniae Antibodies
We are pleased to offer a pair of monoclonal antibodies that are specific for Streptococcus pneumoniae, which are suitable for use in the development of immunoassays.
Check out our FAQ section for answers to the most frequently asked questions about our website and company.